Literature DB >> 18212280

Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.

Takuya Watanabe1, Kae Nishio, Tomoko Kanome, Taka-aki Matsuyama, Shinji Koba, Tetsuo Sakai, Kengo Sato, Shigeki Hongo, Kiyoshi Nose, Hidekazu Ota, Youichi Kobayashi, Takashi Katagiri, Masayoshi Shichiri, Akira Miyazaki.   

Abstract

BACKGROUND: Human salusins, related bioactive polypeptides with mitogenic effects on vascular smooth muscle cells and fibroblasts and roles in hemodynamic homeostasis, may be involved in the origin of coronary atherosclerosis. Macrophage foam cell formation, characterized by cholesterol ester accumulation, is modulated by scavenger receptor (cholesterol influx), acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1; storage cholesterol ester converted from free cholesterol), and ATP-binding cassette transporter A1 (cholesterol efflux). METHODS AND
RESULTS: Serum salusin-alpha levels were decreased in 173 patients with angiographically proven coronary artery disease compared with 40 patients with mild hypertension and 55 healthy volunteers (4.9+/-0.6 versus 15.4+/-1.1 and 20.7+/-1.5 pmol/L, respectively; P<0.0001). Immunoreactive salusin-alpha and -beta were detected in human coronary atherosclerotic plaques, with dominance of salusin-beta in vascular smooth muscle cells and fibroblasts. After 7 days in primary culture, acetylated low-density lipoprotein-induced cholesterol ester accumulation in human monocyte-derived macrophages was significantly decreased by salusin-alpha and increased by salusin-beta. Salusin-alpha significantly reduced ACAT-1 expression in a concentration-dependent manner. In contrast, salusin-beta significantly increased ACAT-1 expression by 2.1-fold, with a maximal effect at 0.6 nmol/L. These effects of salusins were abolished by G-protein, c-Src tyrosine kinase, protein kinase C, and mitogen-activated protein kinase kinase inhibitors. ACAT activity and ACAT-1 mRNA levels were also significantly decreased by salusin-alpha and increased by salusin-beta; however, neither salusin-alpha nor salusin-beta affected scavenger receptor A function assessed by [125I]acetylated low-density lipoprotein endocytosis or scavenger receptor class A and ATP-binding cassette transporter A1 expression.
CONCLUSIONS: Our results indicate that the 2 salusin isoforms have opposite effects on foam cell formation in human monocyte-derived macrophages. Development of atherosclerosis may be accelerated by salusin-beta and suppressed by salusin-alpha via ACAT-1 regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212280     DOI: 10.1161/CIRCULATIONAHA.107.712539

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

1.  Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis.

Authors:  Savas Sipahi; Ahmed Bilal Genc; Seyyid Bilal Acikgoz; Mehmet Yildirim; Yakup Ersel Aksoy; Mehmet Bulent Vatan; Hamad Dheir; Mustafa Altındis
Journal:  Singapore Med J       Date:  2018-10-10       Impact factor: 1.858

2.  Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis.

Authors:  Süleyman Serdar Koca; Metin Özgen; Bahar Işık; Mustafa Necati Dağlı; Bilal Üstündağ; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2014-03-01

3.  Salusin-β Promotes Vascular Calcification via Nicotinamide Adenine Dinucleotide Phosphate/Reactive Oxygen Species-Mediated Klotho Downregulation.

Authors:  Haijian Sun; Feng Zhang; Yu Xu; Shuo Sun; Huiping Wang; Qiong Du; Chenxin Gu; Stephen M Black; Ying Han; Haiyang Tang
Journal:  Antioxid Redox Signal       Date:  2019-12-20       Impact factor: 8.401

4.  IS SALUSIN-ALPHA A NEW MARKER OF CARDIOVASCULAR DISEASE RISK IN HYPOTHYROIDISM?

Authors:  H Usta Atmaca; F Akbas
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

5.  Relationship between Serum Salusin Beta Levels and Coronary Artery Ectasia.

Authors:  Arafat Yildirim; Mehmet Kucukosmanoglu
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

6.  A TOR2A Gene Product: Salusin-β Contributes to Attenuated Vasodilatation of Spontaneously Hypertensive Rats.

Authors:  Shuo Sun; Feng Zhang; Yan Pan; Yu Xu; Aidong Chen; Jian Wang; Haiyang Tang; Ying Han
Journal:  Cardiovasc Drugs Ther       Date:  2021-02       Impact factor: 3.727

7.  Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice.

Authors:  M Nagashima; T Watanabe; M Terasaki; M Tomoyasu; K Nohtomi; J Kim-Kaneyama; A Miyazaki; T Hirano
Journal:  Diabetologia       Date:  2011-07-24       Impact factor: 10.122

Review 8.  Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease.

Authors:  Takuya Watanabe; Kengo Sato; Fumiko Itoh; Kohei Wakabayashi; Masayoshi Shichiri; Tsutomu Hirano
Journal:  Sensors (Basel)       Date:  2012-04-18       Impact factor: 3.576

9.  Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?

Authors:  Urszula Kołakowska; Elżbieta Kuroczycka-Saniutycz; Anna Wasilewska; Witold Olański
Journal:  Pediatr Nephrol       Date:  2014-09-23       Impact factor: 3.714

10.  Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice.

Authors:  Michishige Terasaki; Masaharu Nagashima; Kyoko Nohtomi; Kyoko Kohashi; Masako Tomoyasu; Kyoko Sinmura; Yukinori Nogi; Yuki Katayama; Kengo Sato; Fumiko Itoh; Takuya Watanabe; Tsutomu Hirano
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.